Technical Analysis for EVGN - Evogene

Grade Last Price % Change Price Change
F 2.24 -1.75% -0.04
EVGN closed down 1.75 percent on Friday, November 1, 2024, on 1.97 times normal volume. The bears made the stock sink to a new 52-week low.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Calm After Storm Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Gapped Down Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
20 DMA Resistance Bearish -1.75%
50 DMA Resistance Bearish -1.75%
180 Bearish Setup Bearish Swing Setup -1.75%
New Uptrend Bullish -1.75%
Volume Surge Other -1.75%

   Recent Intraday Alerts

Alert Time
Gap Down Partially Closed about 22 hours ago
Gap Down Closed about 22 hours ago
Reversed from Down about 22 hours ago
Lower Bollinger Band Support about 22 hours ago
Gapped Down (Partial) 1 day ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Evogene Description

Evogene Ltd., a plant genomics company, engages in the development of enhanced plant traits through the use of plant genomics. It primarily focuses on the development of food crops, including corn, soybean, cotton, canola, rice, and wheat, as well as castor for the production of biofuel. The company's technologies include ATHLETE for gene discovery; Gene2Product for enhancing trait efficacy and probability of successful development of biotechnology seed products; and EvoBreed for breeding enhancement. It holds granted or pending patents to approximately 3,000 novel genes. The company has collaboration agreements with Bayer CropScience; Biogemma; Centre de Cooperation Internationale en Recherche Agronomique pour le Development; DuPont; Monsanto Company; Rahan Meristem (1998) LTD; Rasi Seeds (P) Ltd.; Syngenta; Vilmorin; Viterra; and Zeraim Gedera for the development of various products and provision of plant enhancement solutions. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Genomics Crops Soybean Wheat Biofuel Cotton Canola Oil Rehovot Monsanto Seed Products

Is EVGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 10.4
52 Week Low 2.02
Average Volume 311,446
200-Day Moving Average 5.89
50-Day Moving Average 2.79
20-Day Moving Average 2.48
10-Day Moving Average 2.44
Average True Range 0.30
RSI (14) 37.89
ADX 24.08
+DI 21.78
-DI 23.25
Chandelier Exit (Long, 3 ATRs) 2.17
Chandelier Exit (Short, 3 ATRs) 2.92
Upper Bollinger Bands 2.80
Lower Bollinger Band 2.16
Percent B (%b) 0.12
BandWidth 25.83
MACD Line -0.16
MACD Signal Line -0.16
MACD Histogram 0.0048
Fundamentals Value
Market Cap 113.23 Million
Num Shares 50.5 Million
EPS -0.47
Price-to-Earnings (P/E) Ratio -4.77
Price-to-Sales 6.69
Price-to-Book 2.07
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.77
Resistance 3 (R3) 2.76 2.57 2.69
Resistance 2 (R2) 2.57 2.43 2.58 2.66
Resistance 1 (R1) 2.40 2.35 2.49 2.42 2.63
Pivot Point 2.21 2.21 2.25 2.22 2.21
Support 1 (S1) 2.05 2.08 2.13 2.06 1.85
Support 2 (S2) 1.86 1.99 1.86 1.82
Support 3 (S3) 1.69 1.86 1.79
Support 4 (S4) 1.71